scPharmaceuticals Inc banner

scPharmaceuticals Inc
NASDAQ:SCPH

Watchlist Manager
scPharmaceuticals Inc Logo
scPharmaceuticals Inc
NASDAQ:SCPH
Watchlist
Price: 5.67 USD Market Closed
Market Cap: $304.4m

Profitability Summary

scPharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
scPharmaceuticals Inc

Margins Comparison
scPharmaceuticals Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
scPharmaceuticals Inc
NASDAQ:SCPH
302.2m USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
575.5B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
282.2B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
231.1B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
215.7B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
291.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.9B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.2B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
scPharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
scPharmaceuticals Inc
NASDAQ:SCPH
302.2m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
575.5B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
282.2B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
231.1B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
215.7B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
291.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.9B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.2B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
scPharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate